logo
Select company
Select metric
$ -37.53MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
15
Sector
39
Industry
54
History
65
$ 1.54Close
$ 1.16 - $ 5.45 52-Week Range
Ticker Information

Ticker

CRIS

Company Name

CURIS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CURIS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CRIS - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 1.39M$ -38.92M$ -37.53M
3/31/2025$ 1.42M$ -42.13M$ -40.7M
12/31/2024$ 1.48M$ -43.39M$ -41.91M
9/30/2024$ 1.57M$ -45.48M$ -43.91M
6/30/2024$ 1.62M$ -47.57M$ -45.95M
3/31/2024$ 1.63M$ -47.73M$ -46.1M
12/31/2023$ 1.6M$ -47.41M$ -45.81M
9/30/2023$ 1.6M$ -47.03M$ -45.43M
6/30/2023$ 1.57M$ -48.14M$ -46.57M
3/31/2023$ 1.5M$ -52.12M$ -50.62M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CURIS INC's latest trailing twelve months (TTM) EBITDA stands at $ -30.47M.
  • Over the past 5 years, CURIS INC's average EBITDA has been $ -43.5M.
  • The median EBITDA for CURIS INC during this period was $ -44.94M
  • CURIS INC reached its highest EBITDA over the past 5 years at $ -29.59M.
  • The lowest EBITDA recorded by CURIS INC in the same timeframe $ -57.73M

CURIS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
BCAB : BIOATLA INC $ -58.76MCARM : CARISMA THERAPEUTICS INC $ -45.68MCSCIF : COSCIENS BIOPHARMA INC $ -16.25MNXGL : NEXGEL INC $ -2.29MHCTI : HEALTHCARE TRIANGLE INC $ -4.08MMRKR : MARKER THERAPEUTICS INC $ -14.56MJAGX : JAGUAR HEALTH INC $ -38.7MLPCN : LIPOCINE INC $ -4.45MNRXS : NEURAXIS INC $ -7.03MRLYB : RALLYBIO CORP $ -41.54M

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA
EBITDA for CURIS INC is calculated as follows: EBIT [ $ -31M ] + DepAmor [ $ 531K ]
(=) EBITDA [ $ -30.47M ]

CRIS - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -57.73M

Minimum

Sep 30, 2022

$ -29.59M

Maximum

Dec 31, 2020

$ -43.5M

Average

$ -44.94M

Median

EBITDA Benchmark Analysis

The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.87M with a standard deviation of $ 166.99M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.87M
median$ 8.87M
std$ 166.99M